HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Laura A VanBlargan Selected Research
Laura A VanBlargan Research Topics
Disease
20
Infections
02/2022 - 01/2013
11
COVID-19
03/2022 - 10/2020
3
Weight Loss (Weight Reduction)
02/2022 - 08/2021
2
Breakthrough Infections
02/2022 - 08/2021
2
Pneumonia (Pneumonitis)
02/2022 - 08/2021
2
Human Influenza (Influenza)
01/2022 - 12/2021
2
Zoonoses
01/2022 - 12/2021
2
Dengue (Dengue Fever)
11/2021 - 01/2013
1
Vesicular Stomatitis
01/2022
1
Immunologic Deficiency Syndromes
01/2022
1
Primary Immunodeficiency Diseases
01/2022
1
Adenocarcinoma of Lung
01/2021
1
Inflammation (Inflammations)
10/2020
1
Encephalitis (Encephalitis, Rasmussen)
12/2018
1
Flavivirus Infections
12/2018
Drug/Important Bio-Agent (IBA)
11
Vaccines
IBA
02/2022 - 01/2013
8
Antibodies
IBA
03/2022 - 12/2016
6
Neutralizing Antibodies
IBA
03/2022 - 01/2013
6
Monoclonal Antibodies
IBA
03/2022 - 12/2016
5
Proteins (Proteins, Gene)
FDA Link
02/2022 - 01/2018
4
mRNA Vaccines
IBA
02/2022 - 12/2018
4
Epitopes
IBA
01/2022 - 01/2021
2
Messenger RNA (mRNA)
IBA
02/2022 - 01/2022
2
Antiviral Agents (Antivirals)
IBA
01/2022 - 12/2016
2
Influenza Vaccines (Influenza Vaccine)
FDA Link
01/2022 - 12/2021
1
ADM03820
IBA
03/2022
1
Immunoglobulins (Immunoglobulin)
IBA
01/2022
1
Antigens
IBA
01/2022
1
Ad26COVS1
IBA
01/2022
1
2019-nCoV Vaccine mRNA-1273
IBA
01/2022
1
Combined Vaccines
IBA
11/2021
1
Sulfates (Sulfates, Inorganic)
IBA
01/2021
1
Angiotensin-Converting Enzyme 2
IBA
01/2021
1
Broadly Neutralizing Antibodies
IBA
01/2021
1
Nucleoproteins
IBA
10/2020
1
Immunoglobulin A (IgA)
IBA
10/2020
1
Viral RNA
IBA
10/2020
1
Interferons
IBA
01/2018
1
RNA (Ribonucleic Acid)
IBA
01/2018
1
RNA Caps
IBA
01/2018
1
Immune Sera (Antisera)
IBA
09/2015
Therapy/Procedure
5
Therapeutics
03/2022 - 08/2015
1
Intranasal Administration
10/2020